Potential conflict of interest: The authors are employees and shareholders of Bristol-Myers Squibb.
Resistance analysis of hepatitis C virus genotype 1 prior treatment null responders receiving daclatasvir and asunaprevir
Version of Record online: 16 JUL 2013
Copyright © 2013 by the American Association for the Study of Liver Diseases
Volume 58, Issue 3, pages 902–911, September 2013
How to Cite
McPhee, F., Hernandez, D., Yu, F., Ueland, J., Monikowski, A., Carifa, A., Falk, P., Wang, C., Fridell, R., Eley, T., Zhou, N. and Gardiner, D. (2013), Resistance analysis of hepatitis C virus genotype 1 prior treatment null responders receiving daclatasvir and asunaprevir. Hepatology, 58: 902–911. doi: 10.1002/hep.26388
Supported by Bristol-Myers Squibb.
This study is registered with ClinicalTrials.gov, number NCT01012895, and is also known as Study AI447-011.
- Issue online: 29 AUG 2013
- Version of Record online: 16 JUL 2013
- Accepted manuscript online: 15 MAR 2013 07:47AM EST
- Manuscript Accepted: 8 MAR 2013
- Manuscript Received: 18 DEC 2012
Additional Supporting Information may be found in the online version of this article.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.